Uganda has begun a trial vaccination programme for the strain of Ebola viral infection that is behind Sudan's latest outbreak, according to the World Health Organization (WHO), while the number of confirmed cases has risen to three.

Confirmation of Ebola Sudan in Uganda poses a high risk of further spread owing to the index patient's movements across multiple districts and healthcare facilities, the WHO said. It added that rapid containment is critical, because of Kampala's dense population and Mbale's location near the border with Kenya.

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Good morning! Did you know it's

Sudan virus (SUDV) can infect people to cause Sudan virus disease (SVD). Right now, an outbreak of SVD has been detected in Uganda. | Clinical And Molecular Dx

Makerere University, the Uganda Virus Research Institute and the WHO got the Uganda Ebola vaccine trial ready for dosing in just four days.

Ugandan authorities have begun a clinical trial of a vaccine against the Sudan strain of Ebola that has killed one person in the outbreak declared last week.

Kampala, Uganda | THE INDEPENDENT | The Ministry of Health has started rolling out the Ebola Sudan Trial Vaccine to high-risk populations following the recent outbreak in Uganda. This comes after the country registered its eighth outbreak of the Ebola Sudan strain,

If proven effective, vaccine will further strengthen measures to protect communities from future outbreaks,’ says regional director of world health body - Anadolu Ajansı

Ugandan officials are preparing to deploy a trial vaccine as part of efforts to stem an outbreak of Ebola in the capital, Kampala

This is a critical achievement toward better pandemic preparedness and saving lives when outbreaks occur,” said Dr. Tedros Adhanom Ghebreyesus, WHO Director-General.

The vaccine candidate is being evaluated in a ring vaccination trial as part of a comprehensive public health response NEW YORK CITY, NY / ACCESS Newswire / February 3, 2025 / The first participants have been vaccinated with an investigational Ebola